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Abstract
 
The contribution that long-lived bone marrow (BM) plasma cells (PCs) provide to enduring
humoral immunity has been underscored by a number of recent studies. However, little is
known about the immediate precursors that give rise to long-lived PCs in the BM of immune
individuals. We have identified subsets of antigen-experienced B cells within the immune BM
that are precursors to PCs. These PC precursors arise in the BM 14 days after immunization
and persist for greater than 9 months. Phenotypically distinct subsets of PC precursors give rise
to short-lived or long-lived PCs. The differentiation of PC precursors to PCs occurs in the ab-
sence of antigen and requires cell division. The functional significance of these newly identified
PC precursors in the persistence and quality of the humoral immune response is discussed.
Key words: B lymphocyte subsets • antibody formation • cell differentiation • cell lineage • 
immunophenotyping
 
Introduction
 
Plasma cells (PCs)
 
*
 
 are essential for both the immediate and
long-lived antibody response after immunization (1–3). In
response to antigen exposure, PCs arise rapidly in the
splenic red pulp, allowing for immediate production of
protective antibody to acute infections (3–6). These PCs
are typically short-lived and can express isotype switched
Ig. Although red pulp PCs derived from memory cells
could display mutated Ig V regions, the majority of these
cells usually have not acquired Ig V region mutations. In
contrast, long-lived PCs primarily arise weeks after antigen
exposure having accumulated V region mutations due to
selection within the germinal center (GC) (3–6). These
long-lived PCs ultimately reside in the immune bone
marrow (BM) for extended periods and account for over
80% of the antibody present in immune serum (3–7).
Recent studies have underscored the importance of
long-lived PC in sustaining humoral immune responses to
pathogens and to nominal thymus-dependent (TD) anti-
gens (3–6). It is generally considered that antigen-experi-
enced B cells selected within the GC leave the GC and mi-
grate to the BM as PC precursors or as fully matured PCs
(3–6). However, little is known about the identity of the
immediate precursors that generate mature, terminally
differentiated PCs. Much of what is known about PC in-
termediaries is derived from studies of multiple myeloma
(MM), a human cancer identified by the clonal expansion
of PCs in the BM (8). Subsets of PCs within the BM of
MM patients have been delineated via expression of a
number of cell surface molecules, including CD45, CD38,
and CD44, and have been associated with varying prolifer-
ative capacities and patient prognosis (9–11). Although a
clear identification of a progenitor cell has yet to be made,
these studies have revealed a cell lineage representing an in-
termediary stage before terminal PC differentiation (9, 11).
Whereas little is known about the post-GC B cell lin-
eages that give rise to PCs, there is evidence that cellular
intermediaries exist. Advances in our understanding of mo-
lecular events regulating PC differentiation are currently
being resolved. Analyses of the temporal expression of
BLIMP-1 and XBP-1 have identified a distinct matura-
tional pathway of the B cell lineage leading to terminal PC
formation and Ig production (12–15). Overexpression of
BLIMP-1 stimulates terminal B cell differentiation to PC
and deletion of XBP-1 selectively inhibits B cell differenti-
ation before PC formation, but after establishment of GC
(12–15). Hence, factors like XBP-1 may function within
cells that inhabit an intermediary stage between centrocyte
selection and PC formation (13).
 
Address correspondence to Randolph J. Noelle, Department of Microbi-
ology and Immunology, Dartmouth Medical School, 1 Medical Center
Drive, Lebanon, NH 03756. Phone: 603-650-7670; Fax: 603-650-6223;
E-mail: rjn@dartmouth.edu
 
*
 
Abbreviations used in this paper:
 
 ACT, ammonium chloride-Tris buffer;
ASC, antibody-secreting cells; BCS/BSS, bovine calf serum in balanced
salt solution; BM, bone marrow; CFDAse, carboxyfluorescein diacetate
succinimidyl ester; ELISPOT, enzyme-linked immunospot; GC, germi-
nal center; MitoC, Mitomycin C; MM, multiple myeloma; NP, 4-hydroxy-
3-nitrophenyl acetyl; PC, plasma cell; QM, quasi-monoclonal; TD, thy-
mus-dependent; Tg, transgenic. 
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We have used B cells from mice expressing a V
 
H
 
 trans-
gene that has been inserted into the Ig heavy chain locus
(16). The Ig transgenic (Tg) B cells from these mice can be
readily used to follow the fate of antigen-activated B cells
as they differentiate to terminally committed PCs in vivo
(16). Quasi-Monoclonal (QM) Tg B cells bear antigen
specificity to 4-hydroxy-3-nitrophenyl acetyl (NP),
express the V17.2.25 idiotype, and when transferred into
B6-Ly5.2 mice as recipients, are distinctive due to the ex-
pression of IgG
 
a
 
 allotype immunoglobulin and the Ly5.1
congenic marker (16–18). Previous studies have demon-
strated the accurate recapitulation of GC responses by the
Tg B cells after immunization with a TD antigen (16, 18,
19). QM Tg B cells within GC express high levels of PNA
and GL7 and reduced CD38 expression (16). Data pre-
sented in this report demonstrates the ability of these Tg B
cells to terminally differentiate to short-lived and long-
lived BM PCs after immunization with a TD antigen. Fur-
thermore, we have identified precursors present within im-
mune BM that can differentiate to PC upon transfer into
naive recipients. The identity and function of these novel
PC precursors is discussed.
 
Materials and Methods
 
Antibodies and Reagents.
 
The following monoclonal antibod-
ies were used during these studies: mouse IgG
 
1
 
 anti–mouse IgM
 
a
 
(clone DS-1), mouse IgG
 
2a
 
 anti–mouse IgG1
 
a
 
 (clone 10.9),
mouse IgM anti–mouse IgG1
 
b
 
 (clone B68-2), rat IgG
 
2a
 
 anti-
mouse B220 (clone RA3-6B2), rat IgG
 
2a
 
 anti-mouse CD11a
(LFA-1
 
 
 
, clone 2D7), mouse IgG
 
2a
 
 anti-mouse CD45.2 (Ly5.1,
clone 104), mouse IgG
 
2a
 
 anti-mouse CD45.1 (Ly5.2, clone A20),
hamster IgG anti-mouse CD80 (B7-1, clone 16-10A1), Rat
IgG
 
2a
 
 anti-mouse CD86 (B7-2, clone 6L1), rat IgG
 
2a
 
 anti-mouse
CD126 (IL-6R, clone D7715A7), rat IgG
 
2a
 
 anti-mouse CD127
(IL-7R, clone B12-1), rat IgG
 
2a
 
 anti-mouse CD138 (Syndecan-1,
clone 281-2) (BD PharMingen); rat IgG
 
2b
 
 anti-mouse CD49d
(VLA4, clone PS/2), rat IgG
 
1
 
 anti-mouse CD44 (clone KM201)
(Southern Biotechnology Associates, Inc.); anti-V
 
H
 
17.2.25 cell
line (R2348.8), which was provided by T. Imanishi-Kari (Uni-
versity of California San Francisco, San Francisco, CA); and rat
IgG
 
2b
 
 anti I-A (clone M5/114.15.2). NP-KLH and NP-BSA
were purchased from Biosearch Technologies. MultiScreen-HA
96-well plates (Millipore) were used for enzyme-linked immuno-
spot (ELISPOT) assays.
 
Mice.
 
QM and B6-Ly5.2 mice were housed within the ani-
mal facility at Dartmouth Medical School (Lebanon, NH). Gen-
eration of the QM mice has been previously described (20). QM
mice were subsequently backbred to the C57BL/6 J
 
H
 
 
 
/
 
 
 
 J
 
k
 
 
 
/
 
 
 
strain for nine generations. Splenocytes from backcrossed mice
were used for all adoptive transfers.
 
Animals, Adoptive Transfer, and Immunization.
 
After isolation
of splenocytes from QM mice, RBC were lysed via incubation
with ammonium chloride-Tris buffer (ACT) and then depleted
of T cells through anti–Thy-1.2 and complement treatment. The
percentage of Tg QM B cells within the remaining population
was determined by staining 2 
 
 
 
 10
 
5
 
 cells with anti-B220 and
anti-idiotype in 5% bovine calf serum in balanced salt solution
(BCS/BSS) at 4
 
 
 
C and analyzed via a Becton Dickinson FAC-
Scan
 
®
 
 or FACSCalibur
 
®
 
. For each primary transfer, 3 
 
 
 
 10
 
6
 
 QM
B cells were injected via tail vein into B6-Ly5.2 recipient mice.
Typically, three mice were used per experimental group. 1 d after
transfer, recipient mice were injected intraperitoneally with 100
 
 
 
g of NP-KLH emulsified in CFA. Secondary transfers were via
tail vein injection to B6-Ly5.2 mice as noted. Secondary recipi-
ents were not immunized.
 
Measurement of PC Longevity by Irradiation and BM Reconstitu-
tion.
 
To evaluate the longevity of Tg QM PCs within the BM,
we used a whole body irradiation technique previously demon-
strated to identify long-lived PCs (3). Naive B cells, memory B
cells, and short-lived PCs are susceptible to irradiation whereas
long-lived PCs persist after radiation exposure (3). Thus, after
adoptive transfer and immunization, primary recipient mice were
subjected to whole body irradiation. B6-Ly5.2 recipient mice
were irradiated with 600 rad at 7, 14, 28, or 49 d after primary
transfer as specified. All irradiated mice were reconstituted with
3 
 
 
 
 10
 
7
 
 spleen and 3 
 
 
 
 10
 
7
 
 BM cells from a naive B6-Ly5.2
mouse by intravenous tail vein injection. All intravenous recon-
stitutions were performed within 4 h of radiation treatment. The
persistence of long-lived PCs within the BM was measured 3 wk
after irradiation by ELISPOT assay.
 
ELISPOT Assay.
 
Splenic and BM 
 
 
 
NP-specific IgG
 
1
a
 
 anti-
body-secreting cells (ASC) were enumerated by an NP- and allo-
type-specific ELISPOT assay. After isolation of splenic or BM
cells, RBC were lysed via incubation with ACT and T cells de-
pleted through anti–Thy-1.2 and complement treatment. Of the
remaining population, 2.4 
 
 
 
 10
 
6
 
 cells per well were apportioned
to NP-BSA–coated Millipore hemagglutinin 96-well plates and
threefold serial dilutions were made before incubation. Plates
were incubated for 5 h at 37
 
 
 
C within a CO
 
2
 
 incubator. After the
incubation, plates were washed in PBS and 0.5% Tween in PBS
and ASC detected by a biotinylated anti–mouse IgG
 
1
a
 
, followed
by streptavidin-horseradish peroxidase (Amersham Pharmacia
Biotech). ELISPOTS were developed by a chromagen substrate:
AEC (Sigma-Aldrich) in DMF (Fisher Scientific) and 0.1 M
sodium acetate buffer, pH 4.8–5.0. Immediately before develop-
ment of ELISPOTS, 3% H
 
2
 
O
 
2
 
 was added to chromagen sub-
strate. ELISPOTS were enumerated via a dual axis light-
dissecting microscope.
 
Flow Cytometry.
 
After splenic or BM isolation, cells were sus-
pended in ACT for 3 min at 37
 
 
 
C to remove RBC. ACT treat-
ment was not performed with carboxyfluorescein diacetate suc-
cinimidyl ester (CFDAse)-labeled cells. After ACT treatment,
cells were washed and resuspended in 5% BCS/BSS and stained
with the appropriate antibodies as noted. For all studies, nonspe-
cific staining was reduced by the addition of normal rat serum.
Incubation with biotinylated antibodies was followed by incuba-
tion with streptavidin-PE, peridinine chlorophyll protein, or
APC (BD PharMingen). Antibody incubations were for 30 min
at 4
 
 
 
C followed by washing in BCS/BSS. Cells labeled with CF-
DAse (Molecular Probes) were incubated at 37
 
 
 
C for 10 min in
RPMI. The final concentration of CFDAse used was 15 
 
 
 
M in
RPMI with 10–20 million cells/ml. After incubation with CF-
DAse, cells were washed in cRPMI. Stained cells were either an-
alyzed immediately or fixed with 1% formaldehyde in 1.25
 
 
 
PBS. Staining was quantified with either a Becton Dickinson
FACScan
 
®
 
 or FACSCalibur
 
®
 
. A minimum of 500,000 events
were collected and fluorescence signals were detected via four-
decade logarithmic amplification. Spectral overlap compensation
was made with single color-stained samples for each detection
channel. For each experiment, data was analyzed using Becton
Dickinson CELLQuest™ software.
 
Magnetic Bead Isolation of Tg B Cells.
 
QM Tg B cells were
isolated from B6-Ly5.2 mice based on expression of Ly5.1. 
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Magnetic bead purifications were performed according to the
protocol provided by Miltenyi Biotec. BM cells isolated from
recipient B6-Ly5.2 mice were briefly incubated with anti-
mouse biotinylated Ly5.1 antibody (BD PharMingen). BM sam-
ples were then incubated with streptavidin magnetic beads
(Miltenyi Biotec) and cells were positively selected by passage
through LS columns attached to magnetic separators. Flow
through and eluent populations were collected following Mil-
tenyi Biotec protocol guidelines.
 
Mitomycin C (MitoC) Treatment.
 
MitoC (Sigma-Aldrich) was
prepared fresh for each experiment. MitoC was resuspended in
PBS at a final concentration of 0.5 mg/ml in a light-protected
container and filter sterilized. Cells to be treated were resus-
pended at a concentration of 5 
 
 
 
 10
 
7
 
 cells/ml in PBS. MitoC
was added to the cell suspension at a final concentration of 50
 
 
 
g/ml. The cells were then incubated for 20 min at 37
 
 
 
C and
protected from light. After the incubation, cells were washed at
least three times in cRPMI. The viability of cells posttreatment
was analyzed by trypan blue exclusion.
 
Results
 
Generation of Tg BM PCs.
 
After the adoptive transfer of
Tg B cells, the immunization of B6 mice gives rise to a
population of Tg GC B cells (PNA
 
 
 
, GL-7
 
 
 
, CD38
 
 
 
)
(16), and 
 
 
 
NP IgG1
 
a
 
 ASC in the spleen and BM (Fig. 1).
Through the use of an 
 
 
 
NP- and allotype-specific
ELISPOT assay, low frequencies of Tg IgG1
 
a
 
 ASC were
detected early in the spleen (between 7 and 20 d after im-
munization), whereas much higher frequencies appeared
later in the BM after immunization (
 
 
 
20 d) (Fig. 1). For
example, at an early stage of the immune response, 7 d after
immunization, 26 Tg ASC per 2 
 
 
 
 10
 
6
 
 cells were observed
in the spleen of immunized mice. At a later stage of the im-
mune response, 21 d after immunization, 470 Tg ASC per
2 
 
 
 
 10
 
6
 
 cells were observed in the BM of immunized
mice, whereas only 32 Tg ASC were seen within the
spleen. In addition to the ELISPOT analysis, Tg B cells ex-
pressing cytoplasmic IgG
 
a
 
 could be detected in both the
spleen and BM (unpublished data).
 
Characterization of Tg B Cells Present in the BM of Immune
Recipients.
 
Flow cytofluorimetric analysis of immune BM
revealed the presence of a population of Tg B cells as evi-
denced by the expression of the congenic marker Ly5.1
(Fig. 2). This population encompassed 0.6% (
 
 
 
0.3) of BM
cells in over 10 experiments (Fig. 2,
 
 
 
and unpublished data).
In nonimmune mice, this population represented 
 
 
 
0.07%
of the total BM cells (Fig. 2). A phenotypic analysis of the
Ly5.1
 
 
 
 Tg B cells present in the immune BM revealed
characteristics that distinguish these cells from the pheno-
type of naive Tg splenic B cells. Multiparameter analysis of
the Ly5.1
 
 
 
 B cells in the BM revealed that the Tg B cells
expressed higher levels of CD80, CD86, CD126, CD127,
CD138, VLA4, LFA-1, and CD44 when compared with
naive Tg B cells isolated from the spleen (Fig. 2). The Tg B
cells in the BM down-regulated surface MHCII, B220, and
IgM
 
a
 
 expression when compared with naive Tg B cells
(Fig. 2). The Ly5.1
 
 
 
 Tg BM B cells, based on the down-
regulation of MHCII and B220, and the elevated levels of
CD80, CD86, CD138, and CD44, appeared to exhibit a
phenotype that is intermediate between splenic B cells and
end-stage PCs.
 
Isolation of PC Precursors.
 
To determine if the Ly5.1
 
 
 
 B
cells in the BM of immune mice were PCs, Ig production
was examined. Ly5.1
 
 
 
 and Ly5.1
 
 
 
 B cells were purified by
Ly5.1 magnetic bead selection and analyzed for antibody
secretion using an 
 
 
 
NP- and allotype-specific ELISPOT
assay. All of the Tg IgG
 
a
 
 
 
 
 
NP ASC were restricted to the
Ly5.1
 
 
 
 population with none seen in the purified Ly5.1
 
 
 
pool (Fig. 3 A). Hence, the Tg PCs lost the expression of
the CD45.1 allele (Ly5.1), yet retained their capacity to
produce 
 
 
 
NP IgG1
 
a
 
 (Fig. 3 A).
To address whether the Ly5.1
 
 
 
 cells found in the im-
mune BM could give rise to PCs, purified Ly5.1
 
 
 
 B cells
(
 
 
 
90% purity in 10 experiments) were transferred into na-
ive recipients and the emergence of Tg PC in recipient
mice was evaluated. Ly5.1
 
 
 
 cells, which do not produce
antibody upon isolation (Fig. 3 A), give rise to a popula-
tion of 
 
 
 
NP IgG1
 
a
 
 ASCs in the BM upon transfer to na-
ive, secondary recipients (Fig. 3 A). Thus, the Ly5.1
 
 
 
 cells
appear to be PC precursors as defined by their ability to
give rise to PCs after adoptive transfer to naive recipients
in the absence of antigen (Fig. 3 A). Moreover, PC pre-
cursors give rise to PC after adoptive transfer to recombi-
nation activating gene knockout in the absence of antigen
Figure 1. The generation of splenic and BM PCs by Tg  NP-specific
B cells. All transfers and immunizations were performed as previously de-
scribed (16). 3   106 Tg cells were transferred to B6-Ly5.2 recipients,
with three mice per experimental group. 1 d after transfer, recipient mice
were injected intraperitoneally with 100  g of NP-KLH emulsified in
CFA. At 7, 14, 21, and 28 d after immunization, BM and spleen cells
were isolated from recipient mice. Splenic and BM  NP-specific IgGa
ASC were enumerated by an NP- and allotype-specific ELISPOT assay.
ELISPOT assays were performed according to standard Millipore proto-
col using Millipore HA 96-well plates coated with NP-BSA. Data is rep-
resentative of four independent experiments. 
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and T cell help (unpublished data), distinguishing the dif-
ferentiation of precursors from that of memory B cells (2).
Morphologically, the Ly5.1
 
 
 
 PC precursors are a hetero-
geneous population containing lymphoblastoid and plas-
macytoid cells (Fig. 3 B).
 
Tg PC Precursors and Short-lived PC in the BM.
 
The ki-
netics of differentiation from precursor to PC and the lon-
gevity of PCs in immune mice were determined in vivo.
Tg PC precursors (Ly5.1
 
 
 
) and PCs (Ly5.1
 
 
 
) were puri-
fied from BM 14 d after immunization. As before, the iso-
Figure 2. A novel popula-
tion of Tg B cells in the BM of
immune mice that is distinct
from naive B cells and PC. Im-
munization and transfer of Tg B
cells to B6-Ly5.2 mice were per-
formed as described in Fig. 1. 2
wk after immunization, BM cells
were isolated from primary re-
cipients for phenotype analysis.
As a comparison to the BM cells,
Tg splenocytes from naive mice
were also isolated for phenotype
analysis. Expression levels for a
number of cell surface markers
were then determined by three-
color flow cytometry as previ-
ously described (16). All samples
were stained with anti-Ly5.1 and
anti-CD138 antibodies. Expres-
sion patterns for a number of sur-
face markers on Ly5.1 /CD138 
BM cells or Ly5.1 /CD138low
splenocytes were then deter-
mined via staining with either
anti-VLA4, LFA-1, CD126,
CD127, CD80, CD86, CD44,
MHCII, B220, or IgM antibodies.
Figure 3. Identification of a Tg PC precursor. Immunization and transfer
of Tg B cells to primary recipient B6-Ly5.2 mice were performed as de-
scribed in Fig. 1. 2 wk after immunization, BM cells from primary recipi-
ents were isolated, depleted of T cells, and then separated by magnetic bead
purification for Ly5.1 expression. (A) After separation, 105 Ly5.1  or
Ly5.1  cells were transferred to each secondary recipient B6-Ly5.2 mouse,
with three mice per group. 2 wk after transfer, the total of BM cells were
isolated from secondary recipients. The levels of  NP IgGa ASC within
BM populations were enumerated by  NP- and allotype-specific
ELISPOT assays at the time of isolation and postsecondary transfer for sep-
arated and unseparated BM populations. ELISPOT assays were performed as described in Fig. 1. Tg B cells express Ly5.1, whereas endogenous host cells
express Ly5.2. Data is representative of over 10 independent experiments. (B) After magnetic bead selection, cytospin preparations of the Ly5.1  cells
were stained with Wright-Giemsa.  1,000. 
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lated Ly5.1
 
 
 
 subset did not contain high numbers of 
 
 
 
NP
IgG1
 
a
 
 ASC, unlike the Ly5.1
 
 
 
 subset (Fig. 4). Each of
these populations was independently adoptively trans-
ferred into naive recipients in the absence of antigen. The
transfer of the purified Ly5.1
 
 
 
 B cells into naive mice gave
rise to increasing numbers of PCs producing 
 
 
 
NP IgG
 
a
 
over a 30-d period (Fig. 4 A). In contrast, the transfer of
the 
 
 
 
NP IgG
 
a
 
-producing PCs demonstrated a progressive
decline in the number of ASC that persisted over time
(Fig. 4 A). Thus, 2 wk after immunization there is a heter-
ogeneous population of Tg B cells within the immune
BM, which contain a population of PC precursors and a
population of short-lived PCs (Fig. 4 A). A similar obser-
vation was made with endogenous non-Tg PC precursors
and PCs (Fig. 4 B).
 
Precursors Generate Long-lived PCs.
 
The half-life of Tg
PCs at a later time during an immune response to NP was
evaluated by the persistence of ASC in the BM of recipient
mice after irradiation and reconstitution. Slifka et al. (3)
have recently demonstrated that 600 rad of whole body ir-
radiation of mice effectively depletes naive and memory B
cells but does not significantly affect the persistence of BM
long-lived PC. Therefore, the enduring Tg ASC after irra-
diation represent long-lived PC (3, 21, 22). At various
times after immunization, recipient mice were irradiated
and BM was reconstituted to determine the half-life of the
ASC in the BM. The levels of 
 
 
 
NP IgG
 
a
 
 ASC within re-
cipient mice were then assessed 3 wk after irradiation and
BM reconstitution. The PCs present in the BM at 7 and 14
d after immunization appeared short-lived since irradiation
caused 
 
 
 
70% loss in ASC over a 3-wk period (Fig. 5). In
contrast, the PCs present in the BM at 28 and 49 d did not
decay over this 3-wk period after irradiation (Fig. 5).
Hence, the early PCs in the BM are short-lived and the
PCs that emerge after 2–3 wk in the BM are long-lived
(Fig. 5). Thus, the data obtained with this Tg B cell system
substantiates previous observations of PC longevity that
have used polyclonal systems in vivo (1, 3).
Figure 4. Functional capacity of BM PCs and precursors early in the
immune response. Immunization and transfer of Tg B cells to primary re-
cipient B6-Ly5.2 mice were performed as described in Fig. 1. 2 wk after
immunization, BM cells were isolated from primary recipients and de-
pleted of T cells. (A) Endogenous and Tg PC precursors and PCs within
the BM population were then separated by magnetic bead purification for
expression of the Ly5.1 (Tg), or (B) Ly5.2 (endogenous) cell surface
marker. 105 Ly5.1  or Ly5.1  cells were transferred to secondary recipi-
ents for measurement of Tg-derived ASC, whereas 3   106 Ly5.2  or
Ly5.2  cells were transferred to secondary recipients for measurement of
endogenous ASC. Three B6-Ly5.2 mice were used per group. Over a
1-mo period after secondary transfer,  NP IgGa ASC levels within the
recipient BM population were enumerated by an  NP- and allotype-spe-
cific ELISPOT assay. Endogenous  NP IgGb ASC were enumerated at 3
wk after secondary transfer. Data represent the number of ASC found
within the donor populations before adoptive transfer as well as posttrans-
fer. ELISPOT assays were performed as in Fig. 1. Data is representative of
at least three independent experiments.
Figure 5. Kinetics of appearance of short-lived and long-lived Tg PCs
after immunization. Immunization and transfer of Tg B cells to primary
recipient B6-Ly5.2 mice were performed as described in Fig. 1. Primary
recipients were irradiated with 600 rads at 7, 14, 28, or 49 d after transfer
of Tg B cells and immunization. Irradiation protocols were performed as
stated in Materials and Methods and as previously described (3). 3 wk af-
ter irradiation, BM cells were isolated from primary recipients. Tg  NP
IgGa ASCs within the BM populations were enumerated by  NP- and
allotype-specific ELISPOT assay. ELISPOT assays were performed as de-
scribed in Fig. 1. Data is representative of two independent experiments. 
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Proliferation of Precursors Is Necessary for Formation of
Long-lived BM PC.
 
Irradiation not only ablated early
PC survival, but also seemed to ablate the ability of PC
precursors to generate new PC (Fig. 5). One effect of
irradiation would be to inhibit PC precursor prolifera-
tion thereby preventing PC formation. Thus, the re-
quirement of PC precursor proliferation for the genera-
tion of PCs was addressed. PCs and precursors were
isolated, treated with mitoC, and transferred into naive
mice. MitoC treatment did not affect PCs as both
treated and untreated populations continued to produce
antibody at similar levels after secondary transfer (Fig. 6
A). In contrast, mitoC treatment of the PC precursors
ablated their capacity to differentiate into PCs upon
adoptive transfer in secondary recipients (Fig. 6 A).
Furthermore, the ability of PC precursors to proliferate
in vivo was visually observed via CFDAse labeling. Pre-
cursors were briefly CFDAse labeled before secondary
transfer (Fig. 6 B) and cell division was measured as a
function of dye dilution. Proliferation of the precursors
was visualized in the BM of recipient mice 3 d after
transfer as a reduced, heterogeneous CFDAse emission
compared with the high, unimodal staining of the input
cells (Fig. 6 B).
 
Long-lived PC Precursors.
 
Given the ability of PC pre-
cursors to give rise to long-lived PCs (Figs. 4 and 5), we
evaluated their ability to persist in the immune BM over
long periods of time. Indeed, PC precursors could be iso-
lated from the BM of mice immunized 9 mo earlier (Fig.
7). Upon transfer of these precursors, PCs were generated
in the BM of recipient mice (Fig. 7). Thus, both PC and
their precursors are long-lived.
 
Subsets of PC Precursors Give Rise to Short-lived or Long-
lived PC.
 
Functional heterogeneity of the Ly5.1
 
 
 
 B cell
population in immune BM was evaluated by electronically
sorting the precursors based on differences in cell surface
antigen expression. Specifically, Ly5.1
 
 
 
 BM B cells were
purified and sorted based on their expression of CD44 and
CD138 (Fig. 2). Heightened levels of CD138 expression
have been correlated with the differentiation of B cells to
PC, whereas CD44 expression has been implicated in BM
homing and observed on the MM PCs (1, 10, 13). Each of
the sorted populations were transferred to naive mice and
analyzed for their capacity to give rise to 
 
 
 
NP IgG1
 
a
 
-
secreting PC. Single-positive CD44
 
 
 
 and single-positive
CD138
 
 
 
 cells displayed the greatest capacity to generate
long-lived PCs (Fig. 8), whereas the double-positive
(CD44
 
 
 
, CD138
 
 
 
) and double-negative (CD44
 
 
 
, CD138
 
 
 
)
cells produced primarily short-lived PCs in the BM (Fig.
8). Thus, there appears to be a heterogeneous lineage of
PC precursors in the immune BM that give rise to PCs
with varying life spans.
 
Discussion
 
Among the multiple subsets of mature B cells found
within the immune BM, a novel post-GC precursor to
BM PCs has been identified. Thus, in addition to the ex-
istence of memory B cells and PCs, this newly identified
PC precursor contributes to the development of long-
lived humoral immunity (23–25). This novel subset within
the BM is phenotypically distinct from either splenic B
cells or PCs. Unlike mature B cells, this post-GC popula-
tion in the BM downregulates B220, MHCII, and surface
Figure 6. Proliferation is required for the differentia-
tion of precursors to PCs early in the immune response.
Immunization and transfer of Tg B cells to primary re-
cipient B6-Ly5.2 mice were performed as described in
Fig. 1. 2 wk after immunization, BM was isolated from
primary recipients and depleted of T cells. (A) PC pre-
cursors and PCs were then separated by magnetic bead
purification for Ly5.1 expression and a portion of each
fraction was treated with MitoC. MitoC treatment pro-
tocol was derived from methods previously described (3).
Each population was then transferred separately to B6-Ly5.2
secondary recipients. 105 cells were transferred to each re-
cipient. 2 wk after secondary transfer, BM cells were iso-
lated from secondary recipients.  NP IgGa ASCs within
the BM population were then enumerated by  NP- and
allotype-specific ELISPOT assay. ELISPOT assays were
performed as described in Fig.
1. (B) After Ly5.1 isolation, PC
precursors were labeled with
CFDAse and transferred (106
per mouse) to B6-Ly5.2 sec-
ondary recipients. 3 d after
transfer, BM from recipient
mice was stained with anti-
Ly5.1, and CFDAse expression
of the Ly5.1  cells was deter-
mined via FACS® analysis.
Data is representative of two
independent experiments. 
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Ig, but up-regulates the expression of LFA-1, VLA4,
CD80, CD86, CD126, and CD127. Unlike PCs the pre-
cursors express CD45 and do not secrete antibody. More-
over, the precursors are distinct from memory B cells in
the BM due to their down-regulation of B220 (1). The
precursors also exhibit an increased expression of CD138
compared with naive splenic B cells, although this level is
still lower than previously observed on PCs (1). This inter-
mediate level of CD138 might be an indication of the pre-
cursor’s transitional stage of development. These studies
are the first to establish that PC precursors migrate to the
BM, can persist in the BM for extended periods of time,
and can differentiate into PCs in the absence of antigen.
Furthermore, multiple, phenotypically distinct PC precur-
sors appear to exist within the BM; some give rise to
short-lived (CD138
 
 
 
, CD44
 
 
 
) PC, and some give rise to
long-lived (CD138
 
 
 
, CD44
 
 
 
 and CD138
 
 
 
, CD44
 
 
 
) PC.
Finally, upon trafficking to the BM the PC precursors pro-
liferate, which is essential for the differentiation and gener-
ation of mature PCs.
Similar to previous studies of the humoral response to
peptide antigens (1), QM Tg PC formation initiates with a
rise in spleen ASC after immunization with NP. The spleen
ASCs eventually decrease to naive levels, followed by a sus-
tained increase in BM ASC (Fig. 1) (1). This is in contrast
to the sustained ASC levels observed in both the spleen and
BM after viral activation of B cells (3). Although the levels
of Tg ASC in the spleen are lower than previously observed
with either viral or peptide antigen (1, 3), the dissimilarity
can be attributed to contrasts between non-Tg polyclonal
responses and Tg immune responses. Unlike the non-Tg
response to NP that is characterized by a prolonged GC,
which peaks 
 
 
 
2 wk after immunization, QM Tg B cells are
synchronized in such a way that the peak of GC formation
occurs at day 7, and then wanes soon thereafter (16 and un-
published data). Given the brief QM GC reaction, it is not
surprising that the spleen Tg ASC levels would be lower
than observed in non-Tg systems.
An unresolved issue regarding PC maturation is whether
long-lived BM PC are established through the migration of
fully differentiated PCs from secondary lymphoid organs or
through alternative means, such as homing of a PC precur-
sor to the BM (1–3, 24–28). Although it has been shown
that mature PCs can be guided to the BM by a coordinated
pattern of cell surface protein and chemokine receptor ex-
pression (12, 29–31), it is not clear if this is a major means
for the generation of long-lived PCs in the BM. Based on
the data presented we would hypothesize that PC precur-
sors traffic from the spleen and LN and, upon arrival in the
BM, proliferate and differentiate to PCs. If one examines
the kinetics of PC generation in the BM, there is a rapid
rise in the number of PC from 2 to 4 wk after immuniza-
tion. During this period of time the number of mature PCs
being generated in the spleen is declining. Thus, a tenable
Figure 7. PC precursors are long-lived. Immunization and transfer of
Tg B cells to primary recipient B6-Ly5.2 mice were performed as de-
scribed in Fig. 1. BM was isolated from primary recipients 9 mo after
immunization and depleted of T cells. PC precursors and PCs were then
separated by magnetic bead purification for Ly5.1 expression and trans-
ferred separately to B6-Ly5.2 secondary recipients. 6   104 PC precursors
or PCs were transferred to secondary recipients. 2 mo after secondary
transfer, BM cells from secondary recipients were isolated.  NP IgGa
ASC levels within the BM were measured by an  NP- and allotype-spe-
cific ELISPOT assay both before and postsecondary transfer. ELISPOT
assays were performed as described in Fig. 1. Data is representative of two
independent experiments.
Figure 8. Phenotypic and functional diversity of PC precursor subsets.
Immunization and transfer of Tg B cells to primary recipient B6-Ly5.2
mice were performed as described in Fig. 1. PCs and PC precursors were
isolated from primary recipient BM 2 wk after immunization via Ly5.1
magnetic bead selection. The precursor fraction was then further sepa-
rated via FACS® sorting for expression of CD44 and CD138 by fluores-
cent antibody staining. Each population of sorted precursor cells and PCs
were transferred separately to B6-Ly5.2 secondary recipients. 4   104
cells were transferred to each recipient. BM cells were isolated from sec-
ondary recipients over a 1-mo period after transfer.  NP IgGa ASC were
enumerated by an  NP-, allotype-specific ELISPOT assay. ELISPOT
assays were performed as described in Fig. 1. Data is representative of
four independent experiments. 
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hypothesis is that the migration of PC precursors and their
differentiation upon arrival in the BM, and not the migra-
tion of fully matured PCs, is responsible for the burst of
PCs in the BM 3–4 wk after immunization.
The studies presented demonstrate that the immune BM
harbors complex populations of both progenitors and PCs.
Through electronic sorting and transfer, subsets of PC pre-
cursors were identified that gave rise to either short-lived
or long-lived PCs. Even though these newly identified
precursors may be essential to “seed” the BM to give rise to
short-lived and long-lived PCs, the question emerges as to
why these precursors persist for long periods of time in the
face of long-lived PCs. First, it is possible that these precur-
sors replace PCs upon PC attrition. If this were the case,
one would envision a homeostatic mechanism controlling
the total number of PC. Thus, as the numbers of long-lived
PCs decline, or as the levels of immune complexes in the
BM decline, the differentiation of precursors to PCs would
be triggered. Another possible role of precursors might be
that of affinity maturation. A number of studies have ob-
served post-GC affinity maturation (26, 27, 32), and it is
possible that affinity selection of long-lived precursors oc-
curs within the BM. Currently, studies are underway to
determine if the number of PCs or circulating immune
complex regulates the differentiation of the PC precursors
to PCs and if PC precursors can contribute to affinity mat-
uration of the humoral immune response.
The identification of a PC precursor should provide the
opportunity to discover the factors that govern their traf-
ficking and proliferation. Heightened expression of VLA4,
IL-7 receptor, and IL-6 receptor all conform to our current
understanding of the gene products that regulate homing,
growth, and survival of cells destined to traffic to the BM
(29, 30, 33–36). In addition to the importance of the PC
precursors to the regulation of long-lived humoral immu-
nity, the identification of a proliferative precursor in MM
has also been vigorously sought (8, 11, 37). MM, a highly
aggressive tumor involving clonogenic PCs of the BM, is
fatal for the majority of patients diagnosed (8, 11, 37). Tra-
ditional treatments are not effective in MM (8, 11, 37).
This resistance is thought to be maintained by a progenitor
cell that survives primary treatment after the majority of
malignant PCs have been removed (8, 11, 37). The MM
progenitor may then be capable of giving rise to new tu-
mors leading to clinical relapse. The phenotype, prolifera-
tive potential, and differentiative capacities of the PC pre-
cursors are similar to what has been described for possible
MM progenitors (8, 11, 37). Thus, PC precursors are at-
tractive candidates for the normal counterpart of trans-
formed MM progenitors.
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